Bristol Myers Squibb is seeking a Sr Director, Japan External Supply Head, to oversee the global delivery of clinical and commercial products in cell therapy manufactured by CDMOs in Japan. The role requires extensive experience in biologics or cell therapy manufacturing, strong leadership skills, and fluency in Japanese and English
Job Summary
The head of Japan cell therapy external supply is accountable for global delivery of clinical and commercial products manufactured by contract development and manufacturing organizations (CDMOs) located in Japan.
Leading a multidisciplinary and cross-functional matrix team, the role is accountable for strategic partnership management to implement, achieve and maintain reliable supply and performance within the external network.
Accountable for > $100M of spend, driving financial stewardship and sustainable cost reduction without compromising safety, quality or supply is a key challenge to be met.
Matching Summary
Match Score: 85
Bristol Myers Squibb is seeking a Sr Director, Japan External Supply Head, to oversee the global delivery of clinical and commercial products in cell therapy manufactured by CDMOs in Japan. The role requires extensive experience in biologics or cell therapy manufacturing, strong leadership skills, and fluency in Japanese and English.
Skills & Requirements
Must-have
cell therapy external supply
CDMO partnership management
clinical and commercial product delivery
quality and regulatory compliance
supply chain optimization
financial stewardship
Nice-to-have
strategic partnership development
cross-functional matrix team leadership
continuous improvement initiatives
business process development
Key Requirements
10+ years of experience in biopharmaceutical manufacturing or supply chain
Strong technical expertise in biologics or cell therapy commercial manufacturing
Experience with technology transfer and/or start-up phase
Exposure to PMDA, FDA, EMA regulatory agencies
Demonstrated success negotiating complex supply and toll manufacturing agreements with CDMOs